Cancer Therapies
Polymer Platinate Clinical Trials Commence
Published in Cancer Weekly, September 26th, 2000
The first clinical site has received Institutional Review Board (IRB) approval for this study.
The initial Phase I study protocol is designed to determine the maximum tolerated dose, where the dose-limiting toxicity is identified using the standard once every three weeks platinum dosing regimen. This study will be conducted at two European sites, and it is anticipated that IRB approval at the second site will be received shortly.
Polymer platinate AP 5280, a patented compound consisting of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2000-09-26)
More Articles from Cancer Weekly
- Esophageal Cancer
Photodynamic Therapy Effective for Inoperable Tumors - Head and Neck Cancer
Chemotherapy/Radiotherapy Combination Effective for Short-Term Recurrent Tumor Control - Aflatoxins
Researchers Work to Combat Dangerous Fungal Compounds - Hepatocellular Carcinoma
Routine Follow-Up Improves Prospects for Long-Term Survival - Lung Cancer
Weekly Paclitaxel Plus Carboplatin is Safe, Effective in Patients with Advanced Disease - Nasopharyngeal Cancer
Amyloidosis May be Indicative of Malignancy - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
